Aleksandar Rajkovic - Feb 17, 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-fact
Stock symbol
BNGO
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 05:31 PM
Next filing
Jun 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (right to buy) Award $0 +195K $0.00 195K Feb 17, 2022 Common Stock 195K $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a three year period such that the option is fully vested on February 17, 2025, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).